Global Insulin Delivery Systems Strategic Research Report 2024: Market to Reach $16.8 Billion by 2030 – Technological Advancements and Product Innovations Crucial to Future Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Insulin Delivery Systems – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.


Global Insulin Delivery Systems Market to Reach $16.8 Billion by 2030

The global market for Insulin Delivery Systems estimated at US$13.4 Billion in the year 2023, is projected to reach a revised size of US$16.8 Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2023-2030.

The market for insulin delivery systems is poised for significant growth, driven by the rising prevalence of diabetes among the growing global population. By 2024, the global market will see key competitors holding notable percentage market shares. Diabetes prevalence worldwide is increasing due to sedentary lifestyles and an aging population, which augments the growth prospects for insulin delivery devices. As longevity increases, the demand for these devices continues to rise. Developed nations benefit from a favorable reimbursement scenario, creating more opportunities in these markets.

Syringes, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$7 Billion by the end of the analysis period. Growth in the Pens segment is estimated at 4.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $3.6 Billion, While China is Forecast to Grow at 5.8% CAGR

The Asia-Pacific region, facing a growing diabetes epidemic, is expected to see a substantial boost in the adoption of insulin pens. A comprehensive review of insulin delivery devices highlights the importance of these tools in diabetes management.

Increasing awareness about diabetes care has brought more focus on insulin delivery systems. Expanding R&D activities and pioneering new treatments are crucial for market development. Technological advancements and product innovations, such as the advent of smart insulin pens and the emergence of patch pumps for insulin delivery, are pivotal for future growth. These innovations are set to enhance the efficiency and convenience of diabetes management, driving further adoption of advanced insulin delivery systems.

The Insulin Delivery Systems market in the U.S. is estimated at US$3.6 Billion in the year 2023. China, the world’s second largest economy, is forecast to reach a projected market size of US$3.4 Billion by the year 2030 trailing a CAGR of 5.8% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.9% and 4.4% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.2 Billion by the year 2030.

Key Attributes:

Report Attribute
Details

No. of Pages
272

Forecast Period
2023 – 2030

Estimated Market Value (USD) in 2023
$13.4 Billion

Forecasted Market Value (USD) by 2030
$16.8 Billion

Compound Annual Growth Rate
3.3%

 

 

MARKET OVERVIEW

Influencer Market Insights

World Market Trajectories

Insulin Delivery Systems – Global Key Competitors Percentage Market Share in 2024 (E)

Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)

Rising Prevalence of Diabetes Among Growing Global Population Pushes Up Demand for Insulin Delivery Devices

Diabetes Prevalence Worldwide

Sedentary Lifestyle and Ageing Population Augment Growth Prospects

Driven By Increasing Longevity, Ageing Population Augments Demand in the Market

Favorable Reimbursement Scenario Drives Opportunities in Developed Nations

Growing Diabetes Epidemic in Asia-Pacific to Boost Adoption of Insulin Pens

A Review of Insulin Delivery Devices

Global Economic Update

MARKET TRENDS & DRIVERS

Rise in Global Healthcare Spending on Diabetes Bodes Well for Market Growth

Global Healthcare Spending on Diabetes Treatment for the Years 2019, 2025, 2030, 2035 & 2040

Increasing Awareness about Diabetes Care Sheds Focus on Insulin Delivery Systems

Constantly Expanding R&D Activities and New Pioneering Treatments Influence Growth

Technological Advancements and Product Innovations Crucial to Future Growth

Advent of Smart Insulin Pens

Emergence of Patch Pumps for Insulin Delivery

Next-Generation Artificial Pancreas Device Systems Automates Insulin Delivery

Emergence of Oral Insulin as an Alternative Insulin Delivery Method Presents Significant Challenges

High Cost of Insulin Hampers Growth Prospects

Risks Associated with Reuse of Insulin Pen Needles

FOCUS ON SELECT PLAYERS (Total 32 Featured):

B. Braun Melsungen AG

Becton, Dickinson and Company

Eli Lilly and Company

F. Hoffmann-La Roche AG

Insulet Corporation

Medtronic, Inc.

Novo Nordisk A/S

Wockhardt Ltd.

Ypsomed AG

For more information about this report visit https://www.researchandmarkets.com/r/a68fgp

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.